Definium Therapeutics Inc

Financials

Mittelzufluss aus laufender Geschäftstätigkeit -25.35 M-29.42 M-29.6 M-29.57 M-42.98 M -131.56 M Mittelzufluss aus Investitionstätigkeit —-162.46 M-39.54 M15.41 M34.98 M -151.61 M Zahlungsströme aus der Finanzierungstätigkeit 3.81 M1 M19.65 M749 K245.87 M 267.27 M Freier Cashflow -25.35 M-29.42 M-29.6 M-29.57 M-42.98 M -131.56 M

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.